Benylin recall

Benylin Recall: SAHPRA Takes Urgent Action on Toxic Cough Syrup

SAHPRA issues a countrywide recall of two batches of Benylin paediatric syrup after detecting toxic levels, posing fatal risks. Find out more!

The South African Health Products Regulatory Authority (SAHPRA) has taken swift action by recalling two batches of Benylin paediatric cough syrup after discovering elevated levels of diethylene glycol, a toxic substance. This urgent recall comes in response to the potential fatal risks associated with the contaminated syrup. The investigation into the presence of diethylene glycol is ongoing to ensure the safety of consumers.

In a related incident, the Medicines Control Authority of Zimbabwe (MCAZ) has also ordered a recall of Benylin Paediatric 100 ml Syrup, batch number 329304, manufactured by Johnson. This highlights the importance of rigorous regulatory oversight to safeguard public health. The recall serves as a reminder of the critical role regulatory authorities play in monitoring pharmaceutical products for potential risks.

The recall of the Benylin cough syrup by SAHPRA underscores the commitment of regulatory bodies to prioritize public safety. With high diethylene glycol levels detected, the recall aims to prevent any harm to consumers. Safety measures such as these recalls are crucial in maintaining trust in the healthcare system and ensuring the well-being of the population.

As investigations continue into the presence of toxic substances in the cough syrup, regulatory authorities like SAHPRA and MCAZ remain vigilant in protecting public health. The recall serves as a reminder of the importance of stringent quality control measures in pharmaceutical manufacturing to prevent harmful products from reaching the market.